Source link : https://www.newshealth.biz/health-news/fda-panel-to-weigh-in-on-mdma-approval-parents-lost-to-overdose-new-apa-president/
An FDA advisory committee on June 4 will weigh in on Lykos Therapeutics’ new drug application for midomafetamine (MDMA) capsules for treating post-traumatic stress disorder (PTSD). All investigational doses of TEV-‘749 — a once-monthly injection of the atypical antipsychotic olanzapine — significantly improved symptoms of schizophrenia, meeting the primary endpoint of the phase III SOLARIS […]
Author : News Health
Publish date : 2024-05-15 17:30:35
Copyright for syndicated content belongs to the linked Source.
Categories